Insider Shareholders with Direct Ownership of Nrx Pharmaceuticals, Inc. (NRXP)
This section provides a comprehensive overview of the insiders with direct ownership of Nrx Pharmaceuticals, Inc. (NRXP). You can find detailed information about the size and nature of each insider's ownership stake, as well as the latest updates on their holdings.
NRX Pharmaceuticals, Inc. Insider List
| Insider | Adquired | Disposed | Held | # of Trades | Last Transaction |
|---|---|---|---|---|---|
| 570,000 | 0 | 570,000 $718,200 | 4 |
Aug 30, 2023
Added 10.94%
|
|
|
Brac Lending Group Llc
> 10% Shareholder |
0 | 869,565 | 562,435 $708,668 | 1 |
May 24, 2021
Reduced 60.72%
|
|
Jonathan C Javitt
Chief Scientist |
446,332 | 0 | 446,332 $562,378 | 4 |
Aug 23, 2023
Added 18.3%
|
|
Stephen H Willard
CHIEF EXECUTIVE OFFICER |
50,000 | 0 | 50,000 $63,000 | 1 |
Dec 16, 2022
Added 50.0%
|
|
Seth Van Voorhees
CHIEF FINANCIAL OFFICER |
30,000 | 0 | 46,337 $58,384 | 1 |
Dec 16, 2022
Added 39.3%
|
|
Daniel Troy
Director |
43,093 | 0 | 43,093 $54,297 | 1 |
May 24, 2021
Added 50.0%
|
|
Alessandra Daigneault
General Counsel & Secretary |
65,299 | 33,715 | 31,584 $39,795 | 4 |
Sep 02, 2021
Added 29.42%
|
|
Robert Besthof
Interim CEO |
63,710 | 40,000 | 23,710 $29,874 | 2 |
Sep 15, 2021
Reduced 62.78%
|
|
Herbert Raymond Mc Master
Director |
18,300 | 0 | 18,300 $23,058 | 1 |
Aug 26, 2021
Added 50.0%
|
| 1,750 | 0 | 1,750 $2,205 | 1 |
Nov 28, 2022
Added 50.0%
|